A descriptive, open-label, long-term follow-up survey of psychotic patients receiving risperidone long-acting injectable: Preliminary results.

@article{Viala2009ADO,
  title={A descriptive, open-label, long-term follow-up survey of psychotic patients receiving risperidone long-acting injectable: Preliminary results.},
  author={Annie Viala and Françoise Cornic and Cyrine Benamor and Chantal Baldacci and Sma{\"i}l Cheref and Jacques Gauillard and Pascal Martin and François Caroli and Marie No{\"e}lle Vacheron},
  journal={International journal of psychiatry in clinical practice},
  year={2009},
  volume={13 2},
  pages={
          138-46
        }
}
Objective. To assess clinical development in patients with psychotic disorders who received risperidone long-acting injectable (RLAI) in combination with psychosocial interventions as part of daily clinical practice in France. Methods. In this 18-month survey, patients were started on bi-monthly RLAI injections and integrated in a psychosocial treatment programme. Clinical progression was evaluated using the Clinical Global Impression of Severity (CGI-S) and Global Assessment of Functioning… CONTINUE READING
BETA

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

Similar Papers

Loading similar papers…